CARDIOGEN-82 (Rubidium Rb 82 Generator), 140 millicurie, Rx Only, For Elution of sterile nonpyrog...

FDA Drug Recall #D-1684-2012 — Class II — June 1, 2012

Recall Summary

Recall Number D-1684-2012
Classification Class II — Moderate risk
Date Initiated June 1, 2012
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Bracco Diagnostics Inc
Location Princeton, NJ
Product Type Drugs
Quantity 54 generators

Product Description

CARDIOGEN-82 (Rubidium Rb 82 Generator), 140 millicurie, Rx Only, For Elution of sterile nonpyrogenic Rubidium Chloride Rb 82, Manufactured for: Bracco Diagnostics Inc. Princeton, NJ 08543 by Medi-Physics, Inc. South Plainfield, NJ 07080, NDC 0270-0091-01

Reason for Recall

GMP deviation; Sr-82 levels exceeded alert limit specification

Distribution Pattern

Nationwide and United Kingdom

Lot / Code Information

Lot numbers 09101-121251 and 09101-121391

Other Recalls from Bracco Diagnostics Inc

Recall # Classification Product Date
D-1083-2014 Class III VoLumen Barium Sulfate Suspension (0.1 % w/v, 0... Dec 16, 2013
D-914-2013 Class III Tagitol V Barium Sulfate Suspension (40% w/v, 3... Jul 19, 2013
D-885-2013 Class II Gastrografin (Diatrizoate Meglumine and Diatriz... Jun 21, 2013
D-1663-2012 Class III Bracco Diagnostics multihance (gadobenate dimeg... Apr 16, 2012
D-1665-2012 Class II Multihance Multipack (gadobenate dimeglumine) i... Apr 16, 2012

Frequently Asked Questions

cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.